Clinical codes combined with procedure codes increase diagnostic accuracy of Crohn's disease in a US Military health record.
Crohn's disease
irritable bowel syndrome
ulcerative colitis
Journal
BMJ open gastroenterology
ISSN: 2054-4774
Titre abrégé: BMJ Open Gastroenterol
Pays: England
ID NLM: 101660690
Informations de publication
Date de publication:
2020
2020
Historique:
received:
10
01
2020
revised:
06
02
2020
accepted:
07
02
2020
entrez:
11
6
2020
pubmed:
11
6
2020
medline:
25
11
2021
Statut:
epublish
Résumé
Previous examinations of International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes to predict accuracy of diagnosis in inflammatory bowel disease have had limited chart review to confirm diagnosis. We aimed to evaluate using the ICD-9-CM for identifying Crohn's disease (CD) in a large electronic health record (EHR) database. This is a retrospective case-control study with a 3:1 allocation of EHRs of active duty service members diagnosed with CD from 1996 to 2012. Subjects were selected by having two ICD-9-CM codes for CD during the study period. Gastroenterologists reviewed each chart and confirmed the diagnosis of CD by analysing medication history and clinical, endoscopic, histological, and radiographic exams. 300 cases of CD were selected; 14 cases were discarded due to lack of data, limiting our analysis to 284 subjects. Two diagnostic codes for CD had sensitivity, specificity, and positive predictive value (PPV) of 1.0, 0.53, and 0.69, respectively, for confirmed CD. If two encounters listing CD were with a gastroenterologist, the sensitivity, specificity, and PPV was 0.76, 0.81, and 0.80, respectively. If a colonoscopy was performed within 90 days of any three encounters with a CD code, the sensitivity, specificity, and PPV was 0.51, 0.94, and 0.89, respectively. The poor PPV of ICD-9-CM codes in making the diagnosis of CD should be taken into consideration when interpreting results and when conducting research using such codes. Limiting these codes to those patients who have been given this diagnosis by a gastroenterologist, or to those who have had a colonoscopy near the time of diagnosis, increases the PPV.
Sections du résumé
Background and aims
Previous examinations of International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes to predict accuracy of diagnosis in inflammatory bowel disease have had limited chart review to confirm diagnosis. We aimed to evaluate using the ICD-9-CM for identifying Crohn's disease (CD) in a large electronic health record (EHR) database.
Methods
This is a retrospective case-control study with a 3:1 allocation of EHRs of active duty service members diagnosed with CD from 1996 to 2012. Subjects were selected by having two ICD-9-CM codes for CD during the study period. Gastroenterologists reviewed each chart and confirmed the diagnosis of CD by analysing medication history and clinical, endoscopic, histological, and radiographic exams.
Results
300 cases of CD were selected; 14 cases were discarded due to lack of data, limiting our analysis to 284 subjects. Two diagnostic codes for CD had sensitivity, specificity, and positive predictive value (PPV) of 1.0, 0.53, and 0.69, respectively, for confirmed CD. If two encounters listing CD were with a gastroenterologist, the sensitivity, specificity, and PPV was 0.76, 0.81, and 0.80, respectively. If a colonoscopy was performed within 90 days of any three encounters with a CD code, the sensitivity, specificity, and PPV was 0.51, 0.94, and 0.89, respectively.
Conclusions
The poor PPV of ICD-9-CM codes in making the diagnosis of CD should be taken into consideration when interpreting results and when conducting research using such codes. Limiting these codes to those patients who have been given this diagnosis by a gastroenterologist, or to those who have had a colonoscopy near the time of diagnosis, increases the PPV.
Identifiants
pubmed: 32518662
doi: 10.1136/bmjgast-2020-000378
pii: bmjgast-2020-000378
pmc: PMC7254129
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e000378Commentaires et corrections
Type : ErratumIn
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Scand J Gastroenterol. 2017 Feb;52(2):216-221
pubmed: 27797278
Dig Dis Sci. 2014 Oct;59(10):2406-10
pubmed: 24817338
Inflamm Bowel Dis. 2013 Jun;19(7):1421-7
pubmed: 23518811
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1120-1129.e6
pubmed: 27058635
BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000155
pubmed: 28944071
Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A
pubmed: 16151544
Dig Dis Sci. 2010 Sep;55(9):2592-8
pubmed: 20033847
Can J Gastroenterol. 2012 Oct;26(10):711-7
pubmed: 23061064
J Clin Epidemiol. 2014 Aug;67(8):887-96
pubmed: 24774473
Dig Dis Sci. 2010 Jun;55(6):1689-95
pubmed: 20428948
Inflamm Bowel Dis. 2013 Dec;19(13):2725-36
pubmed: 24216689
Am J Epidemiol. 1999 May 15;149(10):916-24
pubmed: 10342800
Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1086-93
pubmed: 19672855
Inflamm Bowel Dis. 2013 Jun;19(7):1411-20
pubmed: 23567779
Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):211-8
pubmed: 12051120